Skip to main content

Biomarin Pharmaceutical Inc 10-Q for FY2024 Q2

Biomarin Pharmaceutical Inc (BMRN)

10-Q 2024-08-05 For: 2024-06-30
View Original
Added on April 12, 2026

About this 10-Q

Biomarin Pharmaceutical Inc filed this 10-Q on August 5, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).

Headline figures

Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$712.03M
up 19.6% from $595.28M a year earlier
Net income
$107.17M
up 91.2% from net income of $56.04M a year earlier
Diluted EPS
$0.55
up 89.7% from $0.29 a year earlier